Jeremy B. Hayden
CIK 1650737 · Chief Legal Officer · last filed 2026-07-06
Jeremy B. Hayden is a Chief Legal Officer who has filed 62 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for SGHT, was dated Oct 1, 2026. Across all open-market trades the lifetime net is −$868.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SGHT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2 MUSICK
IRVINE, CA 92618
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SGHT | Chief Legal Officer | 357,037 | $9.02 | $3.22M | -$878.5K | 23 | 2026-07-06 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | General Counsel | 32,040 | — | — | $0 | 5 | 2019-10-07 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | General Counsel & VP of BD | 3,643 | — | — | $10.0K | 7 | 2017-03-17 |
Recent Filings
62 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-01 | SGHT | Notice (144) | −2,746 | -$24.8K | EDGAR |
| 2026-09-30 | SGHT | Notice (144) | −22,254 | -$208.1K | EDGAR |
| 2026-09-04 | SGHT | Notice (144) | −12,219 | -$101.3K | EDGAR |
| 2026-09-01 | SGHT | Notice (144) | −13,253 | -$110.0K | EDGAR |
| 2026-08-17 | SGHT | Notice (144) | −12,014 | -$97.8K | EDGAR |
| 2026-08-14 | SGHT | Notice (144) | −48,000 | -$395.9K | EDGAR |
| 2026-08-13 | SGHT | Notice (144) | −2,500 | -$20.8K | EDGAR |
| 2026-08-12 | SGHT | Notice (144) | −16,302 | -$133.3K | EDGAR |
| 2026-08-11 | SGHT | Notice (144) | −20,918 | -$165.9K | EDGAR |
| 2026-07-06 | SGHT | Notice (144) | −12,733 | -$70.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.